Co-Authors
This is a "connection" page, showing publications co-authored by James Chalmers and Stefano Aliberti.
Connection Strength
3.912
-
Additional important research priorities for bronchiectasis in China. Eur Respir J. 2017 01; 49(1).
Score: 0.701
-
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J. 2021 04; 57(4).
Score: 0.235
-
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults. Eur Respir Rev. 2019 Mar 31; 28(151).
Score: 0.203
-
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training. Breathe (Sheff). 2018 Dec; 14(4):269-275.
Score: 0.199
-
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration. Eur Respir J. 2018 11; 52(5).
Score: 0.199
-
A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018 12; 145:120-129.
Score: 0.198
-
The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018 09; 52(3).
Score: 0.196
-
Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Am J Respir Crit Care Med. 2018 06 01; 197(11):1410-1420.
Score: 0.193
-
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018 02; 51(2).
Score: 0.188
-
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network. Eur Respir J. 2018 01; 51(1).
Score: 0.187
-
Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J. 2017 12; 50(6).
Score: 0.187
-
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017 09; 50(3).
Score: 0.183
-
European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 09; 50(3).
Score: 0.183
-
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration. Breathe (Sheff). 2017 Sep; 13(3):180-192.
Score: 0.183
-
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For. Respiration. 2017; 93(3):228-229.
Score: 0.175
-
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study. Chest. 2017 06; 151(6):1247-1254.
Score: 0.175
-
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis. Int J Mol Sci. 2018 Oct 20; 19(10).
Score: 0.049
-
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018 08; 52(2).
Score: 0.049
-
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis. Chest. 2018 05; 153(5):1177-1186.
Score: 0.047
-
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling. Am J Respir Crit Care Med. 2017 09 01; 196(5):609-620.
Score: 0.046
-
High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis. Eur Respir J. 2017 07; 50(1).
Score: 0.045
-
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017 06; 49(6).
Score: 0.045
-
Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot study. Univ Louisville J Respir Infect. 2017; 1(1):3-11.
Score: 0.044